Tag: HIV | Page 12 | CATIE Blog

3 things to keep in mind about trans (men’s) inclusion in HIV prevention research

May 19, 2015 • By Ayden Scheim

In response to mounting evidence of the prevention benefits of pre-exposure prophylaxis (PrEP) use by HIV-negative gay and bisexual men, a discussion recently emerged on social media about the perceived exclusion of trans men1 who have sex with men from PrEP research studies. In fact, trans men participate in many HIV prevention research studies, whether or not they are identified as trans when results are reported. Some do not identify as trans, but rather as men of trans experience or transitioned men, and are happy to check the “male” box without qualification. Other studies have explicitly included trans men and...

There is a drug to prevent HIV. Why isn’t it approved in Canada?

March 30, 2015 • By Bob Leahy

Recent developments in prevention are pointing to worrying gaps in the community-based approach to HIV prevention in Canada. Perhaps we have been used to having only a single prevention technology on our books for so long – think condoms – that our ducks are not always in a row when new ones like PrEP come along. Thus potholes in our response become apparent – and none leap in to fix them. After a series of somewhat inconclusive PrEP trials, whose results were marred by adherence issues, the results of more stringent trials like the PROUD and IPERGAY studies are in,...

Program science: Taking the guesswork out of prevention

February 2, 2015 • By Zak Knowles

For those of us who work in HIV and Hep C prevention, the advent of new prevention approaches has made us increasingly dependent on evidence for making informed decisions about the best strategies to use with a particular client or community.

Share and conquer: Pooling our programming know-how

January 12, 2015 • By Erica Lee

A while back, CATIE wanted to find out what’s been done across the country to assess the frontline needs of HIV and hepatitis C service providers and service users. As the information specialist (or librarian) here at CATIE, I was duly tasked with locating whatever reports I could find.

A clinician’s perspective on the criminalization of women living with HIV

December 15, 2014 • By Dr. Mona Loutfy

In Canada and in much of the Western world, thanks to the advent of combination antiretroviral therapy, there has been a clear improvement in health status and increased life expectancy of people living with HIV approaching that of the general population. However, despite these medical advances, negative public perception about HIV has yet to catch up to the reality that most clinicians encounter. The reality for the most part is of healthy and conscientious patients looking to improve their quality of life.

Where is HIV hitting hardest?

December 1, 2014 • By admin

While HIV does not discriminate and can affect anyone, Canada’s HIV epidemic is concentrated in key populations – a result of both biological risk factors and the social determinants of health. While roughly one out of every 10,000 Canadians is newly infected with HIV every year, the HIV incidence rate is much higher among Aboriginal peoples, Canadians born in countries where HIV is endemic, people who inject drugs, and men who have sex with men.